Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 2
1986 1
1987 1
1988 1
1989 1
1990 1
1991 2
1992 1
1993 1
1994 2
1995 3
1996 3
1997 18
1998 6
1999 5
2000 5
2001 7
2002 9
2003 16
2004 18
2005 6
2006 6
2007 8
2008 9
2009 13
2010 24
2011 17
2012 25
2013 16
2014 17
2015 29
2016 26
2017 31
2018 36
2019 32
2020 35
2021 44
2022 39
2023 41
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

501 results

Results by year

Filters applied: . Clear all
Page 1
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease.
Khan S, Barve KH, Kumar MS. Khan S, et al. Curr Neuropharmacol. 2020;18(11):1106-1125. doi: 10.2174/1570159X18666200528142429. Curr Neuropharmacol. 2020. PMID: 32484110 Free PMC article. Review.
Thus, a standard drug regimen ensues in every Alzheimer's patient, irrespective of the cause, which may not always be beneficial in halting or reversing the disease progression. ...METHODS: In this review, we have compiled existing hypotheses to explain the cause of …
Thus, a standard drug regimen ensues in every Alzheimer's patient, irrespective of the cause, which may not always be beneficial in h …
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.
Charidimou A, Boulouis G, Frosch MP, Baron JC, Pasi M, Albucher JF, Banerjee G, Barbato C, Bonneville F, Brandner S, Calviere L, Caparros F, Casolla B, Cordonnier C, Delisle MB, Deramecourt V, Dichgans M, Gokcal E, Herms J, Hernandez-Guillamon M, Jäger HR, Jaunmuktane Z, Linn J, Martinez-Ramirez S, Martínez-Sáez E, Mawrin C, Montaner J, Moulin S, Olivot JM, Piazza F, Puy L, Raposo N, Rodrigues MA, Roeber S, Romero JR, Samarasekera N, Schneider JA, Schreiber S, Schreiber F, Schwall C, Smith C, Szalardy L, Varlet P, Viguier A, Wardlaw JM, Warren A, Wollenweber FA, Zedde M, van Buchem MA, Gurol ME, Viswanathan A, Al-Shahi Salman R, Smith EE, Werring DJ, Greenberg SM. Charidimou A, et al. Lancet Neurol. 2022 Aug;21(8):714-725. doi: 10.1016/S1474-4422(22)00208-3. Lancet Neurol. 2022. PMID: 35841910 Free PMC article.
BACKGROUND: Cerebral amyloid angiopathy (CAA) is an age-related small vessel disease, characterised pathologically by progressive deposition of amyloid beta in the cerebrovascular wall. ...We derived the Boston criteria version 2.0 (v2.0) by selecting MRI features to optim …
BACKGROUND: Cerebral amyloid angiopathy (CAA) is an age-related small vessel disease, characterised pathologically by progressive dep …
Alzheimer's disease: early diagnosis and treatment.
Chu LW. Chu LW. Hong Kong Med J. 2012 Jun;18(3):228-37. Hong Kong Med J. 2012. PMID: 22665688 Free article. Review.
Magnetic resonance brain imaging, cerebrospinal fluid biomarkers, and Pittsburgh compound B and fluorodeoxyglucose positron emission tomography of the brain can facilitate an accurate diagnosis of Alzheimer's disease in its early stage, and diagnose the mild cogniti …
Magnetic resonance brain imaging, cerebrospinal fluid biomarkers, and Pittsburgh compound B and fluorodeoxyglucose positron emission tomogra …
Treatment of Alzheimer's Disease: Beyond Symptomatic Therapies.
Buccellato FR, D'Anca M, Tartaglia GM, Del Fabbro M, Scarpini E, Galimberti D. Buccellato FR, et al. Int J Mol Sci. 2023 Sep 9;24(18):13900. doi: 10.3390/ijms241813900. Int J Mol Sci. 2023. PMID: 37762203 Free PMC article. Review.
In an ever-increasing aged world, Alzheimer's disease (AD) represents the first cause of dementia and one of the first chronic diseases in elderly people. ...Treatment strategies are aimed to mitigate symptoms, i.e., acetylcholinesterase inhibitors (AChEI) and the N …
In an ever-increasing aged world, Alzheimer's disease (AD) represents the first cause of dementia and one of the first chronic …
Towards clinical utility of polygenic risk scores.
Lambert SA, Abraham G, Inouye M. Lambert SA, et al. Hum Mol Genet. 2019 Nov 21;28(R2):R133-R142. doi: 10.1093/hmg/ddz187. Hum Mol Genet. 2019. PMID: 31363735 Review.
Prediction of disease risk is an essential part of preventative medicine, often guiding clinical management. ...In this review, we summarize the potential use cases for seven common diseases (breast cancer, prostate cancer, coronary artery disease, obesity, type 1 d …
Prediction of disease risk is an essential part of preventative medicine, often guiding clinical management. ...In this review, we su …
Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility.
Karikari TK, Ashton NJ, Brinkmalm G, Brum WS, Benedet AL, Montoliu-Gaya L, Lantero-Rodriguez J, Pascoal TA, Suárez-Calvet M, Rosa-Neto P, Blennow K, Zetterberg H. Karikari TK, et al. Nat Rev Neurol. 2022 Jul;18(7):400-418. doi: 10.1038/s41582-022-00665-2. Epub 2022 May 18. Nat Rev Neurol. 2022. PMID: 35585226 Review.
Well-authenticated biomarkers can provide critical insights into the biological basis of Alzheimer disease (AD) to enable timely and accurate diagnosis, estimate future burden and support therapeutic trials. ...
Well-authenticated biomarkers can provide critical insights into the biological basis of Alzheimer disease (AD) to enable time …
The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease.
Shen S, Liao Q, Wong YK, Chen X, Yang C, Xu C, Sun J, Wang J. Shen S, et al. Int J Biol Sci. 2022 Jan 1;18(3):983-994. doi: 10.7150/ijbs.66871. eCollection 2022. Int J Biol Sci. 2022. PMID: 35173531 Free PMC article. Review.
Studies have shown that such inflammation and impaired insulin signaling contribute to the development of Alzheimer's disease (AD). Therefore, new therapeutic strategies are needed for the treatment of T2DM and T2DM-linked AD. ...Melatonin levels are downregu …
Studies have shown that such inflammation and impaired insulin signaling contribute to the development of Alzheimer's disease …
National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome.
Katz DI, Bernick C, Dodick DW, Mez J, Mariani ML, Adler CH, Alosco ML, Balcer LJ, Banks SJ, Barr WB, Brody DL, Cantu RC, Dams-O'Connor K, Geda YE, Jordan BD, McAllister TW, Peskind ER, Petersen RC, Wethe JV, Zafonte RD, Foley ÉM, Babcock DJ, Koroshetz WJ, Tripodis Y, McKee AC, Shenton ME, Cummings JL, Reiman EM, Stern RA. Katz DI, et al. Neurology. 2021 May 4;96(18):848-863. doi: 10.1212/WNL.0000000000011850. Epub 2021 Mar 15. Neurology. 2021. PMID: 33722990 Free PMC article. Review.
Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease.
Veitch DP, Weiner MW, Aisen PS, Beckett LA, DeCarli C, Green RC, Harvey D, Jack CR Jr, Jagust W, Landau SM, Morris JC, Okonkwo O, Perrin RJ, Petersen RC, Rivera-Mindt M, Saykin AJ, Shaw LM, Toga AW, Tosun D, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative. Veitch DP, et al. Alzheimers Dement. 2022 Apr;18(4):824-857. doi: 10.1002/alz.12422. Epub 2021 Sep 28. Alzheimers Dement. 2022. PMID: 34581485 Free PMC article. Review.
METHODS: We identified 1442 publications using ADNI data by conventional search methods and selected impactful studies for inclusion. RESULTS: Disease progression studies supported pivotal roles for regional amyloid beta (Abeta) and tau deposition, and identified underlyin …
METHODS: We identified 1442 publications using ADNI data by conventional search methods and selected impactful studies for inclusion. RESULT …
Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer's Disease and Other Types of Dementing Disorders.
Minoshima S, Mosci K, Cross D, Thientunyakit T. Minoshima S, et al. Semin Nucl Med. 2021 May;51(3):230-240. doi: 10.1053/j.semnuclmed.2021.01.002. Epub 2021 Feb 2. Semin Nucl Med. 2021. PMID: 33546814 Review.
In the brain, [F-18]FDG accumulates around synapses and represents local neuronal activity. ...Various guidelines have been published to support the appropriate use of [F-18]FDG PET for clinical dementia workup. PET images with [F-18]FDG demonstrate distinct …
In the brain, [F-18]FDG accumulates around synapses and represents local neuronal activity. ...Various guidelines have been published …
501 results